Promising response with PI3K inhibitor for a patient with heavily pretreated PIK3CA mutation head-and-neck cancer

The treatment options for patients with head-and-neck squamous cell carcinoma (HNSCC) are limited when the disease progresses after taking platinum, a PD-1 inhibitor, and cetuximab. To develop new agents for managing such pretreated malignancies, therapies targeting carcinogenic pathways could be po...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of cancer research and practice 2023-04, Vol.10 (2), p.75-77
Hauptverfasser:	Lee, Ming-Jing, Kao, Hsiang-Fong
Format:	Artikel
Sprache:	eng
Schlagworte:	Antimitotic agents Antineoplastic agents Development and progression Genetic aspects Patient compliance Squamous cell carcinoma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!